MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/15209156251383516

Медицинская библиотека · Diabetes technology & therapeutics · 2025

Medication Use in Type 1 Diabetes and the Association with Socioeconomic Disadvantage: Analysis of a National Linked Dataset.

Zomer Ella, Morton Jedidiah I, Chen Lei, Talic Stella, McAuley Sybil A, Davis Elizabeth A, Jones Timothy W, Lomax Kate E, Magliano Dianna J, Shaw Jonathan E, Zoungas Sophia

СтатьяПеревод в очереди

Аннотация

OBJECTIVES

To explore trends in the receipt of commonly prescribed medications (beyond insulin) in people with type 1 diabetes in Australia, including polypharmacy, and to investigate socioeconomic disparities across these trends.

METHODS

A retrospective analysis of 68,287 people with type 1 diabetes registered on the National Diabetes Services Scheme between 2013 and 2019, and linked to the Australian pharmaceutical claims database to capture medication use. The proportion of people with type 1 diabetes dispensed a medication class was assessed in each year, and by levels of Index of Relative Social Disadvantage.

RESULTS

The study population comprised 37,055 (54.3%) males and 31,232 (45.7%) females captured between 2013 and 2019, with an overall median age of 38.8 (interquartile range [IQR]: 26.1-53.3) years and median diabetes duration of 17.0 (IQR: 7.9-25.7) years. The median number of medications used in the study population was five (IQR: 3-8). Trends in receipt of commonly prescribed medications remained relatively stable between 2013 and 2019, except for the use of noninsulin (adjuvant) glucose-lowering agents, which increased. In 2019, compared with people in the least disadvantaged areas, those in the most disadvantaged areas were more likely to be receiving adjuvant glucose-lowering therapy (crude rates 21.5% vs. 11.6%), antihypertensive therapies (36.1% vs. 28.8%), lipid-lowering therapies (35.7% vs. 29.7%), antithrombotic medication (8.9% vs. 5.6%), proton pump inhibitors (25.2% vs. 17.1%), medications for asthma (13.2% vs. 8.4%), and medications for mental health (27.5% vs. 21.5%). Polypharmacy (defined as ≥5 medications) was more likely in those in the most disadvantaged areas compared with those in the least disadvantaged areas (58.8% vs. 48.5%). Even after adjustment for patient factors, differences in medication use and polypharmacy across socioeconomic strata persisted.

CONCLUSIONS

Receipt of commonly prescribed medications in type 1 diabetes and polypharmacy were associated with increased socioeconomic disadvantage.

Для цитирования: Zomer Ella, Morton Jedidiah I, Chen Lei, Talic Stella, McAuley Sybil A, Davis Elizabeth A, Jones Timothy W, Lomax Kate E, Magliano Dianna J, Shaw Jonathan E, Zoungas Sophia. Medication Use in Type 1 Diabetes and the Association with Socioeconomic Disadvantage: Analysis of a National Linked Dataset.. Diabetes technology & therapeutics. 2025. DOI: 10.1177/15209156251383516.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.